Fig. 1From: The direct prognosis comparison of 125I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancerKaplan–Meier survival curves of bRFS (A), cRFS (B), CSS (C) and OS (D) in patients with IRPC treated with LDR vs RP. bRFS biochemical relapse-free survival, cRFS clinical relapse-free survival, CSS cancer-specific survival, OS overall survival, IRPC intermediate-risk prostate cancer, LDR low-dose-rate brachytherapy, RP radical prostatectomyBack to article page